{"name":"Onchilles Pharma Inc","slug":"onchilles-pharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxOdVJYSFlfSU9NSS03VzBlSXJ2YmRrN2NVSmhfR3pHUHR4SlFIOHNXVkU2ZUI3NDJGWU1Ba0JkY2VKSFdtY3F3MUNOckVmS1RWUWo2UDZ1VTh4ZXVXejNETHdwU192Z3BnXzU4RWx4UXBwcWxpNjl3VGx3d0c3U0Jlc1E0bUtiT0VKYThiNjE0b2JpQW04VWJhbUgxaWpVUG9Yd0M2X3ctRzNxUk90aDhpR0FPaHVMaS1fOVVJUE1CbENSZXRVYW9tNlNvdlpxdE9EYzhMZnQzNUhDaTVjTWt2aHVOMmlHZE9jeU1fWnQyemtVQQ?oc=5","date":"2026-03-17","type":"trial","source":"Business Wire","summary":"Onchilles Pharma to Present New Preclinical Data on Systemically Delivered NEU-002 Program at AACR 2026 - Business Wire","headline":"Onchilles Pharma to Present New Preclinical Data on Systemically Delivered NEU-002 Program at AACR 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNSXF0Z0pnTWE0b1hQc3BuZmdzLWdIcWRkVXpaNHNvSmlxTEZTcDZUdGFHRzJqWC1xUENFM2RlSTAxSktCZmJwSzl2bmZta2NWeVMxRWhvLUxlWDVram52S0Y1Ums0cGNhLVI3YU91ak5pVlpvWUhWdXhHYXNTNnhnbks4Tmh3UThXb3ZQVWNOaEJhaHFYc1BBTjF5NzFwVGdiQkRaNzlR?oc=5","date":"2026-02-03","type":"pipeline","source":"BioWorld News","summary":"Onchilles Pharma’s N-17350 gains IND clearance for solid tumors - BioWorld News","headline":"Onchilles Pharma’s N-17350 gains IND clearance for solid tumors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgJBVV95cUxPbktSejEtdVh5MFhOeGFuZ1JfcF9ubG1oVk9Hai00RDQ4NXZRcE5lMFJjMXhWSlZVVUdZZl8wZzlqOXYtZEJqWkxTbi1NMWpJVHJ6enU2ZHRRSVFqVjVSYWZhbFJUdVVsakVXSFVna1VjQ0x2WnpBOVFSbWhYai1XUzhLTHc2WUZrVGFvUVVmUU9sMmpBdExhcTdfRUFKTjBic3h6RGwzSEFRbTlrcFlnTk1aYTBxTDZlbThuaGgwZ01lZzdSLVNtYXowaTFEUjhQTGtyY0s1ZmhfN3lzRHM3VF9kQWY3Z3plbDVoUEE1Q0pQbEx0N2Q4dzhHMFFSSDJwckFlUzBlcEVIY0NSXy1tWTVESkxBVWdPRmJ5OFNDYkp3WkpfUVFGNl9Ua0JjSVFKYlJ6ZXNB?oc=5","date":"2026-02-02","type":"pipeline","source":"Business Wire","summary":"Onchilles Pharma Announces IND Clearance for N17350, Advancing the First Next-Generation Cytotoxic Therapeutic Leveraging the ELANE Pathway into the Clinic - Business Wire","headline":"Onchilles Pharma Announces IND Clearance for N17350, Advancing the First Next-Generation Cytotoxic Therapeutic Leveragin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxPYy1fclZNcHp2SWFUODZLaDVoZmRoUWZOdUxpV0pLZ0FIVnp0aHdPN1d5WUgwWlFpaF9aVjBDSFdGMHpNc0hydmxta3FwQkNLdVB6YUsxaElXd3FfOVhHNUN6QTVmSUUzQ3M2NkRkNU1rQ2trMjNEeHBaRnBkcThjc3RObWJuMUE3VG1uM0VQb1VReWV0VDd6UTVKdVI2MmRVcllNYkkxdkdyYTNFQ3lqWHRFN2pIa0JJMnotZWpKWUtnSTE2RVNOMGw1dzROR1YwcW9HWlhiNWtaYlFSTWpRNVhDcUdUajJ0RU01Rk1xeElRVWFEUmlvell0elRQNExQaWR5bDg3RUhfVXMxVFVnNXJqTHJzc1RpTmN0cW5NZldUcTFO?oc=5","date":"2025-11-07","type":"trial","source":"Business Wire","summary":"​​Onchilles Pharma Publishes Landmark ELANE Pathway Study and Advances N17350 Toward the Clinic With New Financing and Leading Clinical Advisor - Business Wire","headline":"​​Onchilles Pharma Publishes Landmark ELANE Pathway Study and Advances N17350 Toward the Clinic With New Financing and L","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBWNm05cGNUcktfLS1GYUZiR2l4OGIwUUNxRC1paFBiSWo3azdPdlBEQ1lUMzJJRXdRQWNyWUs3bFY1S2dKZldhMENXT2NiWE51WU9B?oc=5","date":"2025-11-07","type":"pipeline","source":"FirstWord Pharma","summary":"Onchilles raises $25M for biologic that attacks cancer on two fronts - FirstWord Pharma","headline":"Onchilles raises $25M for biologic that attacks cancer on two fronts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNN3AxM3Rpc1FDRzlRNjhNOThwLWxENWVsNE9zY21iN2hrbUlPYVNRY1lWMWRRQUZGZS1kY1FFSEI0ZENLOXRRSnZHMHVjemU0R2ppd21fMkdfNEhaTTYtend0YlJ2ZW1Hd0JGTE5zUFpFamdWcDFQUk1mNWdHaFo5MUNSS24xRWt4Y0R0LXB4RWF3b1Y4dzJjTkV1MVRXYTdiRUJieU54aGloQmhqZ2FTZ0ZjMDNYcmxGR2ljUk50OHNZYnpmTkpv?oc=5","date":"2025-11-07","type":"pipeline","source":"HIT Consultant","summary":"Onchilles Pharma Raises $25M to Advance N17350, Pioneering Next-Gen Cytotoxic Cancer Therapy - HIT Consultant","headline":"Onchilles Pharma Raises $25M to Advance N17350, Pioneering Next-Gen Cytotoxic Cancer Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxNOW5sNm1sWnc2QlV2SEFsNFBpSFlSajlOTDVTcDFZQTMyZjZ1VkVNb01PWXpMeFBZczA5Z2RReDM2X3ZTMk80RGhwVjdya2taRXBoNFlQaVNpMzVYZjI4S3o0YUVMVGZpajlFUENYOC01c1RoV09teVFYU3VuYjZ4WnpIWThIa00zMzRGajZjQTJweWJOMk1YODE2Q0VlN1FhNGVjcXdoRGRXY3pJeF80Znl3cER2QzlkelhRRDBDYTNPUFlmaDhYWk1SdlgzQVNxQ2dwSVV5dEF1dEZZWUpLeXV6cWtmZmxXRE11UUhsWU9FczZkdWpBUTg4SmJGajItRmloT2pOSQ?oc=5","date":"2025-04-25","type":"trial","source":"BioSpace","summary":"Onchilles Pharma Presents New Data at AACR 2025 Highlighting N17350, a Next-Generation Cytotoxic Therapeutic Leveraging the ELANE Pathway - BioSpace","headline":"Onchilles Pharma Presents New Data at AACR 2025 Highlighting N17350, a Next-Generation Cytotoxic Therapeutic Leveraging ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxQREI4OTI2SjUzdmVjU3JmZHFBOWpVem1zUkNIM0N6dmhxa0laWFhWdFNTa2IyREtPRE1BMWo0d0tnNzJUMFI2Q1NmMnZBdHRza20yZktkYVloUUVpREtJWGNPZGg0UG5ZNDZkanV6OUFPV1hRcG1FeFhVZ1lNOGxHMl9SYkRWQnF2bTFCYUFXNXJPbk5BT3RCbU11cm12cVMxamxtUWt3TzRHZmprd0Y2dXE2RklDRWpEeFZOV0hZazRmOGxHZzNiOWR4MUhrN1A0MlVDX1hUNVR4QTg5VUgyNEpBTDVuNkg4YUVCSTBnNEhaN1lHNDFkYmZWSUNYSGJJU1dRVG5VSnhMM2NydlBhaWtaZEFiSHds?oc=5","date":"2025-01-13","type":"trial","source":"Business Wire","summary":"Onchilles Expands Leadership Team to Advance First-in-Class Pan-Cancer Therapeutics Targeting the ELANE Pathway into Clinical Trials - Business Wire","headline":"Onchilles Expands Leadership Team to Advance First-in-Class Pan-Cancer Therapeutics Targeting the ELANE Pathway into Cli","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNUWlBX0FjaTdSQWVsaGpYR3g3ZC1RV3pOdmpkUzd2WWYyWmRVRWN2Q2JyQTdmbXYxT1RrcGNQcWxjZ3k2bGZEdVZOT0ozTUkxT0VoYnBqTHBmakJzYzhrbERuTG1ZTW44TzAzejFVb0NSNXgyOEZ5LUs1emkxVGZPNHFDM2d5VXRtbS1tUFhTSWJ4Qi1TaTFmUXpTMFJIZEpBWjhSblJxU2hPWDRDR3JTZzZDRWYtQmN0X1E?oc=5","date":"2024-10-04","type":"trial","source":"BioSpace","summary":"Onchilles Pharma Announces Presentation of Data for the NEU-002 Program at SITC 2024 - BioSpace","headline":"Onchilles Pharma Announces Presentation of Data for the NEU-002 Program at SITC 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNN0Y3cnZCZmRpYVNydWY2SEVxeFZVTkR2TmN4REtLTm5IdV9tbWdXUlZPMUdDSXdCWmdLWFFCcHJqMHN3UC1jSE4xbVNpVXRrVnRCeDhZb1pZXzJZTVQ4YTMyVzBsR091Q0xnSkVJOE1rTUFSNTcydUJKeU96azFDcndwR2NFZlhOY0dFeGVNLUVGZU41RGVrVUloWUo4cVhlQldXUTFCVmYtZWJLNUE?oc=5","date":"2023-04-19","type":"pipeline","source":"Polsky Center for Entrepreneurship and Innovation","summary":"Onchilles Pharma Advancing Tumor-Killing Drug Candidate to the Clinic - Polsky Center for Entrepreneurship and Innovation","headline":"Onchilles Pharma Advancing Tumor-Killing Drug Candidate to the Clinic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxONG51YmJKOW16eTBPRVJEWUhIZmZuck1vTVdkZmRtdUpqVV8ydklvdV9yZFVrSWwtSi1UeXF5TDQ3cXdaVEJGNmdUelFmczdoVUQtblJ2TlpIS2VOcDVzdUVrWmw2UFo1SXVhY1dZdG1rcWZUNWRFVk0yeW9nVWhpcVBXY29ZM290Nzh3QUJPQzYzOGFhWVo2eHhUUnM2R0d2TDRwMW84SVI2d3FMNzM0M2t3c1lsaHZKSHkzNUkwVXY2VS0tUVZCSjJpSldsUmdnNWlnV2g0QmRRdkk1ZVQzVzQ5RjlFdEU5TkpsY29vcmprc2loTGVSeUVSdk1LQXp5WXZrOE13ai1fSFVYeEkwQWV6VWJaenNXN1E?oc=5","date":"2021-06-10","type":"pipeline","source":"Business Wire","summary":"Onchilles Pharma Raises $7 Million Series A to Advance Drug Candidates to Activate Newly Discovered Broad-Acting Anticancer Pathway - Business Wire","headline":"Onchilles Pharma Raises $7 Million Series A to Advance Drug Candidates to Activate Newly Discovered Broad-Acting Antican","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}